Reduction in cardiac mitochondrial calcium loading capacity is observable during α-naphthylisothiocyanate-induced acute cholestasis: a clue for hepatic-derived cardiomyopathies?  by Oliveira, Paulo J et al.
Reduction in cardiac mitochondrial calcium loading capacity is observable
during a-naphthylisothiocyanate-induced acute cholestasis:
a clue for hepatic-derived cardiomyopathies?
Paulo J. Oliveiraa,*, Anabela P. Rolob, Raquel Seicac, Maria S. Santosb,
Carlos M. Palmeirab, Anto´nio J. Morenob
aCentro de Neurocieˆncias de Coimbra, Unidade de Investigaca˜o Ba´sica em Cardiologia, Instituto de Investigaca˜o em Luz e Imagem,
Universidade de Coimbra, Azinhaga de Sta. Comba, P-3000-354 Coimbra, Portugal
bCentro de Neurocieˆncias de Coimbra, Dep. Zoologia, Faculdade de Cieˆncias e Tecnologia, Universidade de Coimbra, P-3004-517 Coimbra, Portugal
cFaculdade de Medicina, Centro de Neurocieˆncias de Coimbra, Universidade de Coimbra, P-3004-517 Coimbra, Portugal
Received 25 April 2002; received in revised form 24 September 2002; accepted 17 October 2002
Abstract
Cardiovascular changes of still obscure origin are sometimes correlated with co-existing liver diseases, as cholestasis.
The aim of this work was to examine and compare cardiac mitochondrial bioenergetics and calcium loading capacity from rats injected
with a single dose of a-naphthylisothiocyanate (ANIT), a cholestasis-inducing compound. Forty-eight hours after ANIT administration,
blood samples were collected and markers for hepatic disease were determined. Heart mitochondria from both control and ANIT-injected rats
were isolated and subjected to biochemical characterization, including the susceptibility to the calcium-dependent permeability transition.
The results showed that cardiac mitochondria from cholestatic animals did not have significant changes in respiratory parameters or in the
basal levels of adenine nucleotide. The most impressive result from this work was that cardiac mitochondria from ANIT-injected animals had
a lower calcium loading capacity. The prevention of this property by cyclosporin-A, a specific inhibitor of the mitochondrial permeability
transition, showed that this phenomenon was reason for the reduced calcium loading capacity in ANIT-injected animals. The results suggest
that, during the development of ANIT-induced cholestasis, heart mitochondria loose their default ability to buffer calcium. Our results may
contribute to explain the occurrence of cardiomyopathies sometimes associated with cholestatic disease.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Liver diseases are one of the leading causes of death in
the world. Cholestasis, defined as impaired bile flow, occurs
in many chronic human liver diseases. During this condi-
tion, many toxic hydrophobic bile salts normally secreted by
the liver into bile are now accumulated inside the hepatocyte
[1]. The accumulation of toxic hydrophobic bile salts is
associated with liver failure, leading ultimately to biliary
fibrosis and cirrhosis. The mechanisms underlying these
pathological events are not fully clear. A possible reason for
hepatic dysfunction may be an increased production of
reactive oxygen species [2,3] or an increased susceptibility
of hepatocytes to apoptotic cell death [4]. Mitochondria can
be central points in bile salts-induced hepatic dysfunction.
Hepatic mitochondrial membrane perturbations were al-
ready observed during cholestasis [5], leading to indirect
toxic effects on the mitochondrial respiratory complexes
[6–8]. Thus, the accumulation of bile salts in the hepatocyte
cytoplasm may directly affect hepatic mitochondria. Some
of bile salt-induced perturbations include the triggering of
the mitochondrial permeability transition (MPT#), a phe-
nomenon linked to the formation and opening of protein
pores (the MPTP) in the inner mitochondrial membrane [9].
MPTP opening can be caused by excessive mitochondrial
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calcium accumulation and oxidative stress generation [10],
and can lead ultimately to cell death [11]. Bile salts were
already related to the MPT [11,12]. In fact, Gores et al. [12]
proposed that the activation of mitochondrial proteases may
initiate the MPT and cell necrosis during cholestasis. In
apparent contradiction, cholestasis in bile duct-ligated rats
was described conferring resistance to rat liver MPT [14].
The observations are not in contradiction with the general
pro-inducing role of bile salts in the MPT if we recall that
some bile salts can indeed confer protection against MPT
induction [15,16]. The secondary plasma accumulation of
bile salts was also proposed as a causative factor for hepatic
cardiomyopathy and heart dysfunction [17]. An adverse
effect of bile salts in the h-adrenoceptors density and
affinity, as well as in the plasma membrane fluidity, was
also already described [18], although the relevance of this
work is questionable by the fact that the tested concentra-
tions exceeded the highest concentrations seen so far in the
plasma. Taurocholate, a tauroconjugated primary bile acid,
was found to impair rat cardiomyocyte function, hindering
the normal cellular calcium dynamics [19]. It is pertinent to
question if cardiac mitochondria may be affected the same
way as hepatic mitochondria by the increased amount of bile
salts in the plasma. More particularly, in this work, we were
interested in comparing the susceptibility of heart mitochon-
dria to the permeability transition in a-naphthylisothiocya-
nate (ANIT)-induced cholestatic rats to verify if it affected
mitochondrial calcium loading capacity. ANIT is known to
selectively produce hyperbilirubinemia, cholestasis and bile
duct obstruction [20], in relation with increased inflamma-
tory response in the mostly affected areas [21]. As far as we
know, no direct effect of ANIT in the cardiac tissue is
known.
The objective of this work was to compare some aspects
of heart mitochondrial bioenergetics, especially concerning
the induction of the calcium-sensitive MPTP, in both ANIT-
injected and control rats. Our results showed that cardiac
mitochondrial permeability transition was enhanced in cho-
lestatic animals, despite non-significative alterations on
bioenergetic parameters. This type of effect was not mim-
icked by ANIT addition to isolated heart mitochondria. We
hypothesise that mitochondrial dysfunction due to enhanced
permeability transition may be one of the causes leading to
cholestatic derived cardiomyopathy.
2. Materials and methods
2.1. Materials
All reagents and chemicals were of the highest grade of
purity commercially available. Calcium Green 5-N was
obtained from Molecular Probes, Eugene, OR. ANIT was
dissolved in olive oil before use for in vivo administration or
in dimethylsulfoxide for in vitro testing in isolated heart
mitochondria.
2.2. Animals
Female Wistar rats (12–15 weeks) were maintained in
our local colony (Laboratory Animal Research Center,
University Hospitals, Coimbra) with ad libitum access to
food (URF1-Charles River, France) and water at pH 4.5.
The room temperature and moisture were kept at 22–24 jC
and 50–60%, respectively. The animals were subjected to a
12 h day/night cycle. In this study, the ‘‘Principles of
Laboratory animal care’’ (NIH publication no. 85–23,
revised 1996) were followed.
2.3. Induction and characterization of cholestasis
Rats were randomly divided in two groups of seven
animals each. Acute cholestasis was induced in one group of
animals with a non-fasting intraperitoneal injection of
ANIT, 100 mg/kg. Control animals were injected with olive
oil alone. Animals were kept 48 h before the experiments.
Rats were then anaesthetized (i.m.) with ketamin chloride
(88.5 mg/kg, Parke-Davis USA) and chlorpromazine chlor-
ide (2.65 mg/kg, Lab. Victoria, Portugal) and their weight
was recorded (anesthetics were without effect in our results;
data not shown). An arterial blood sample (1 ml) was taken
from the descending aorta for measurement of liver injury
serum markers. The analysis was conducted using commer-
cial kits (Olimpus, Japan-Novadia and Beckmann, Eus-
Izaza). Non-used injected animals survived the single ANIT
administration.
2.4. Isolation of mitochondria from rat heart
Forty-eight hours after ANIT administration, one animal
of each group were sacrificed and hearts excised. Rat heart
mitochondria from both rats were prepared as previously
described [22]. Mitochondrial protein content was deter-
mined by the biuret method calibrated with BSA.
2.5. Measurement of mitochondrial transmembrane poten-
tial
The mitochondrial transmembrane potential (DW) was
estimated with a TPP+ electrode according to the equation of
Kamo et al. [23], without correction for the ‘‘passive’’
binding contribution of TPP+ to the mitochondrial mem-
branes (as the purpose of the experiment was to show
relative changes in the potential rather than absolute values).
A matrix volume of 1.1 Al/mg protein was assumed and
valinomycin was used to calibrate the basal line. Reactions
were carried out at 25 jC in 1 ml of the reaction media (200
mM sucrose, 10 mM TRIS–MOPS, 10 AM EGTA, 5 mM
KH2PO4 and 2 AM rotenone, pH 7.4) supplemented with 1
AM TPP+, 0.25 Ag oligomycin and 0.5 mg of mitochondria.
Mitochondria (0.5 mg) were energised with 4 mM succi-
nate. DW values before and after the addition of a calcium
pulse were determined.
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2.6. Mitochondrial oxygen consumption
Oxygen consumption of isolated heart mitochondria
was monitored polarographically with a Clark oxygen
electrode connected to a suitable recorder simultaneously
with DW measurement. Reactions were carried out, at 25
jC, in 1 ml of the reaction media composed by 200 mM
sucrose, 10 mM TRIS–MOPS, 10 AM EGTA, 5 mM
KH2PO4 and 2 AM rotenone, pH 7.4. Mitochondria were
suspended at a concentration of 0.5 mg/ml in the respi-
ratory medium. State 4 respiration was measured in the
presence of 4 mM succinate. ADP (100 nmol) was added
to induce state 3 respiration. The respiratory control ratio
(RCR) was calculated as the ratio between state 3 and
state 4 respiration. The ADP/O was calculated as the
number of nmol ADP phosphorylated by natom oxygen
consumed.
2.7. Extramitochondrial calcium movements
Extramitochondrial free Ca2 + was measured with the
hexapotassium salt of the fluorescence probe Calcium Green
5-N [24]. Heart mitochondria (0.2 mg) were suspended in 2
ml of buffer containing 200 mM sucrose, 10 mM TRIS-
MOPS, 10 AM EGTA (for complexing basal calcium), 1
mM KH2PO4, 2 AM rotenone, 4 mM succinate and 0.05 Ag
oligomycin. Free Ca2 + was monitored in the presence of
100 nM Calcium Green 5-N. Fluorescence was recorded
continuously in a water-jacketed cuvette holder at 25 jC
using a Perkin-Elmer LS-50B fluorescence spectrometer
with excitation and emission wavelengths of 506 and 531
nm, respectively.
2.8. Quantification of adenine nucleotides
ATP and ADP were extracted using an alkaline extrac-
tion procedure and were separated by reverse-phase high
performance liquid chromatography. The chromatographic
apparatus was a Beckman-System Gold, consisting of a 126
Binary Pump Model and a 166 Variable UV detector,
controlled by computer. The detection wavelength was
254 nm, and the column was a Lichrospher 100RP-18 (5
Am) from Merck (Darmstadt, Germany). An isocratic elu-
tion with 100 mM phosphate buffer (KH2PO4), pH 6.5 and
methanol 1% was performed with a flow rate of 1 ml/min.
The time required for each analysis was 5 min.
2.9. Statistical analysis
The results are presented as meanF S.E. of at least five
independent experiment days. Statistical analyses were
performed using two-tailed unpaired t-tests. A P value
< 0.05 was considered statistically significant. In some
cases, we present representative recordings of six independ-
ent days, with one mitochondrial preparation from each
group tested simultaneously.
3. Results
The results of biochemical analysis and body weight
from both animal groups are summarised in Table 1. All
Table 1
Blood biochemistry and body weight from control and ANIT-treated
animals
Control
animals
ANIT-injected
animals
Statistical
significance
Total proteins
(g/dl)
7.72F 0.09 6.74F 0.19 P< 0.01
Albumin (g/dl) 3.55F 0.06 2.64F 0.09 P< 0.0001
Serum alanine
aminotransferase
(U/l)
54.17F 3.39 338.14F 48.22 P< 0.001
Alkaline
phosphatase
(U/l)
136.50F 9.67 284.29F 25.82 P< 0.001
Gama-glutanyl-
transpeptidase
(U/l)
0.17F 0.17 3.86F 0.14 P< 0.0001
Total bilirubin
(mg/dl)
0.10F 0.00 5.11F 0.29 P< 0.0001
Direct bilirubin
(mg/dl)
0.00F 0.00 3.39F 0.19 P< 0.0001
Serum aspartate
aminotransferase
(U/l)
117.33F 18.95 419F 63.31 P< 0.01
Body weight (g) 205.43F 12.99 193.14F 12.99 P< 0.01
Plasma was obtained from blood samples collected at the day of the
experiments.
Biochemical analyses were performed using commercial kits, as described.
Values are meansF S.E. of seven animals tested. Blood analyses were
compared using an unpaired t-test. Body weight was compared with a
paired t-test.
Table 2
Basal intra-mitochondrial ATP/ADP ratio, mitochondrial respiratory
parameters and DW values in succinate-energised from control and
ANIT-treated animals
Control
animals
ANIT-injected
animals
Statistical
significance
DW (mV) 215.8F 1.9 213.2F 2.1 n.s.
State 4
(natoms O/min/
mg protein)
89.95F 14.14 93.78F 14.30 n.s.
State 3
(natoms O/min/
mg protein)
264.73F 9.29 221.35F 37.05 n.s.
RCR 3.28F 0.41 2.63F 0.38 n.s.
ADP/O 1.75F 0.05 1.88F 0.05 n.s.
Basal ATP/ADP 0.52F 0.07 0.50F 0.06 n.s.
State 4 respiration was measured in the presence of 8 mM succinate (plus 4
AM rotenone). ADP (100 nmol) was added to induce state 3 respiration.
The RCR was calculated as the ratio between state 3 and state 4 respiration.
The ADP/O was calculated as the number of nmol ADP phosphorylated by
natom oxygen consumed.
Values are meansF S.E. of five separate experiments and were compared
using a two tailed unpaired t-test.
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markers of hepatic liver disease were increased in the
plasma of ANIT-injected animals. Total bilirubin concen-
tration, a cholestasis index, was significantly higher in the
ANIT-injected animals than in control animals. A decrease
in the total protein content and serum albumin was also
observed in ANIT-injected animals, as well as a decrease in
body weight of 15.14F 4.69 g.
Heart mitochondria were isolated from both control and
ANIT-injected animals and respiratory parameters were
characterised, as well as the basal ATP/ADP ratio, deter-
mined 4 h after the isolation procedure (Table 2). As seen,
no significant differences were obtained in the studied
parameters. The ADP/O ratio (number of nmol ADP phos-
phorylated per natoms O consumed) was slightly but not
statistical significantly increased in ANIT-injected animals.
Also, no significant differences were seen in the basal ATP/
ADP charge.
The maintenance of mitochondrial DW levels after cal-
cium addition indicated mitochondrial tolerance to calcium
addition. A representative recording of the differences
between both groups regarding mitochondrial DW fluctua-
tions is pictured in Fig. 1, left panel. After the addition of
one calcium pulse, mitochondria from control and ANIT-
injected animals suffered a depolarisation motivated by the
entry of positive charges inside the mitochondrial matrix.
Control heart mitochondria were able to repolarise to normal
values after calcium accumulation; in opposition, their
counterparts from ANIT-injected animals were not able to
repolarise and DW was eventually lost. This complete loss
of mitochondrial DW was related to MPTP induction, as
Fig. 1. Left panel: Typical recording of mitochondrial electric potential measured with a TPP+-selective electrode. Calcium (600 AM) was added in order to
induce the MPTP. The DW was calculated as described. Mitochondrial energization was achieved with 4 mM succinate. Trace A: Heart mitochondria from
cholestatic rats in the presence of 0.5 AM cyclosporin-A. Trace B: Heart mitochondria from control rats. Trace C: Heart mitochondria from cholestatic rats.
Mitochondrial DW was measured simultaneously with oxygen consumption. The traces are representative of five different experiment days, with one sample of
each group tested. Right panel: Statistical comparison between mitochondrial DW developed by succinate-energized mitochondria from control and ANIT-
injected animals before (black bars) and 3 min after calcium addition (white bars), in the presence and absence of 1 AM cyclosporin-A (CyA). *P < 0.05 vs.
control + calcium+ cyclosporin-A, **P< 0.001 vs. ANIT (without calcium) vs. ANIT+ calcium+ cyclosporin-A and vs. control + calcium, n= 5.
Fig. 2. Left panel: Extramitochondrial calcium movements measured with the fluorescent calcium-sensitive probe Calcium Green 5-N. Extramitochondrial
calcium was determined as described in Materials and methods. Trace A: Heart mitochondria from cholestatic rats. Trace B: Heart mitochondria from control
rats. The recording shown here was typical of six different experiment days, with one sample of each group tested. Right panel: Extramitochondrial calcium
concentration 1600 s after calcium addition for the two groups in the presence and absence of cyclosporin-A (CyA). *P < 0.001 vs. control and vs.
ANIT + cyclosporin-A, #P< 0.001 vs. control + cyclosporin-A, n= 6.
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cyclosporin-A, the specific MPTP inhibitor [9,10], was able
to prevent the DW loss in mitochondria from ANIT-injected
animals. Cyclosporin-A was also able to slightly increase
the DW repolarisation in cardiac mitochondria from the
control group (Fig. 1, right panel). It is noticeable that no
significant differences between the DW developed by both
mitochondrial groups were found in the absence of calcium
(Fig. 1, right panel).
In concordance with DW results, energised heart mito-
chondria from ANIT-injected rats were not capable to
accumulate calcium (using 200–300 nmol calcium pulses
per mg protein) the same way as control mitochondria did
(Fig. 2, left and right panel). In the presence of cyclosporin-
A, both mitochondrial populations were able to accumulate
the same calcium amount (right panel). As before, cyclo-
sporin-A also increased calcium accumulation in the control
group (Fig. 2, right panel).
A strong possibility for the observed results would be a
possible direct toxic effect of ANIT in the cardiac mito-
chondrial population. We added ANIT to a suspension of
isolated heart mitochondria and tested their capacity to
sustain DW values after calcium pulses. In fact, ANIT only
showed toxic effects for concentrations near 1 Amol/mg
protein (500 AM in the reaction buffer, totally outside the
range involved in our in vivo assays) (data not shown). Even
for those concentrations, the addition of EGTA and the
presence of cyclosporin-A were unable to prevent ANIT
toxic effects (data not shown).
4. Discussion
In our study, a single dose of ANIT caused an increase
in the serum levels of hepatic enzymes, a known marker
for cholestatic disease [25]. Serum bilirubin was also
increased, indicative of hepatocellular damage with or
without simple biliary obstruction. The reduction of the
total serum protein content and more particularly of serum
albumin was also an indication for liver damage [25].
Taken together, the results indicated that the single injec-
tion of ANIT was causative of cholestatic liver disease.
This condition also contributed for the observed decrease
in animal weight (see Table 1).
Our study was the first one to relate cardiac mitochon-
drial dysfunctions with hepatic cholestasis disease. We
compared some values typically used in mitochondrial
bioenergetics in succinate-energised mitochondria, as that
substrate is normally used for MPTP assays. As seen in
Table 2, no statistical differences were observed in the
mitochondrial bioenergetic parameters in both groups,
although the ADP/O value was slightly higher in the
ANIT-group. It is not the first time that a disease condition
is shown to increase the ADP/O value, as it was already
observed in GK rats, an animal model for type II diabetes
[26]. Nevertheless, this increase in the efficiency of cardiac
mitochondrial phosphorylative system could act as an adap-
tation response to the disease condition. The unchanged
RCR and the ATP/ADP value may also be another evidence
of adaptation.
The mitochondrial permeability transition is a condition
often related to mitochondrial dysfunction. In this work,
we primarily investigated the differences between heart
mitochondria from ANIT-injected and control rats in the
susceptibility to the calcium-dependent permeability tran-
sition. A rather large calcium concentration (500–600 AM)
was used in our experiments. In our hands, a high re-
sistance to in vitro calcium-induced MPTP characterizes
isolated cardiac mitochondria in the absence of strong pro-
oxidants (as it is the case here). The results allowed us to
conclude that heart mitochondria from ANIT-injected ani-
mals were more susceptible to the induction of the
permeability transition. This fact disturbed the default
mitochondrial calcium loading capacity in ANIT-injected
animals. Importantly, the equivalent inhibitory effect of
cyclosporin-A, the specific MPT-inhibitor, in either mito-
chondrial DW and calcium movements, allowed us to
conclude that an enhanced MPT is the solo reason for
the loss of calcium loading capacity in heart mitochondria
isolated from cholestatic rats. We also observed some
protection afforded by cyclosporin-A in the control group.
This clearly demonstrated that a small sub-set of calcium-
susceptible mitochondria existed in that group. Neverthe-
less, the apparent number of those susceptible mitochon-
dria was bigger in the cholestatic group.
Presently, we are not able to determine the main mech-
anism for the enhanced susceptibility to the calcium-sensi-
tive permeability transition. Nevertheless, it is probable that
the increase of bile salts in the cardiomyocyte cytoplasm
may induce perturbations in mitochondrial membranes, as
already described for hepatic mitochondria [5], which may
prone mitochondria to suffer the MPT. Other possibility, not
tested in this study, is that bile salts may directly increase
mitochondrial oxidative stress and thus cause the opening of
the MPTP by this pathway. This is in agreement with the
protective role of antioxidants in the apoptotic effect of bile
salts [13]. Nevertheless, differences in the endogenous
calcium content did not seem to be a possible cause, as
seen by experiments using a mitochondrial uncoupler in
mitochondria without external calcium addition (not
shown). A direct effect of ANIT in the myocardium was
also excluded for several reasons. One of them was the lack
of ANIT effect on the MPTP in isolated cardiac mitochon-
dria in concentrations up to 500 AM (a concentration that
would be unreachable in the cardiac tissue during our in
vivo treatment) (data not shown). Furthermore, experiments
with liver mitochondria isolated from the same animals
showed an opposite result: hepatic mitochondria from
ANIT-injected animals showed a higher calcium loading
capacity [27]. Also, our results are also in clear contra-
diction with the results ones with the hepatic MPT in bile-
duct ligation-induced cholestatic rats [14], although differ-
ent organs may have a different response to the same
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stimulus and the liver is known to resist very well to disease
conditions.
It is important to notice that this defective mitochondrial
capacity in buffering externally added calcium was only
accompanied by slight or no changes on other mitochondrial
parameters. The RCR value, which gives us the degree of
coupling between the mitochondrial protonmotive force and
ATP synthesis, was not affected in ANIT-injected animals.
Moreover, the ADP/O value was even slightly increased.
The role of the MPT in cellular dysfunction is well
documented [28,29]. Cardiac dysfunction sometimes asso-
ciated with cholestatic liver disease can be associated with an
increased susceptibility of heart mitochondria to the perme-
ability transition. The decrease in mitochondrial function in
situ that normally accompanies an enhanced permeability
transition may hinder the normal myocardial function.
Although our experimental conditions may seem very arti-
ficial (specially concerning the high calcium concentrations
used), it is known that microdomains may exist between
mitochondria and the sarcoplasmic reticulum, creating
domains where calcium concentrations felt by one single
mitochondrion are much higher than in bulk cytosol [30].
Also, it is known that a higher calcium amount is necessary
to induce the MPTP in vitro when succinate and rotenone are
present in the reaction buffer [9,10]. The presence of the
mentioned compounds creates conditions to generate a high
degree of reduction of intra-mitochondrial pyridine nucleo-
tides, which antagonises MPTP induction for lower calcium
matricial concentrations [10]. It is feasible that in vivo
conditions, with lower ratios between reduced and oxidised
intramitochondrial pyridine nucleotides due to mitochondrial
complex I activity, may allow for a MPTP induction for
much lower calcium conditions, as it happens in isolated
cardiac mitochondria (Oliveira, unpublished results).
We are tempted to suggest that the alteration of bile acids
levels in the plasma (although not measured in this work) or
other increased metabolite may be also toxic for cardiac
cells and especially for cardiac mitochondria, leading ulti-
mately to cardiovascular bioenergetic alterations. Moreover,
our results also suggest that patients with hepatic diseases
translated into defective cardiac mitochondrial calcium
handling may not resist so well to cardiac ischemia and
reperfusion episodes. As far as we know, no clinical data is
available concerning this.
Our results may be very helpful in the comprehension of
possible cardiac problems associated with an increase of bile
salts in the plasma and opens new horizons for the treatment
of cardiac problems associated with hepatic dysfunction.
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